会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • BIS(HETERO)ARYL CARBOXAMIDE DERIVATIVES FOR USE AS PGI2 ANTAGONISTS
    • 用作PGI2拮抗剂的BIS(HETERO)ARYL CARBOXAMIDE DERIVATIVES
    • WO2004069805A1
    • 2004-08-19
    • PCT/EP2004/000711
    • 2004-01-28
    • BAYER HEALTHCARE AGMURATA, ToshikiSHINTANI, TakuyaUMEDA, MasaomiLINO, TakashiMORIWAKI, Toshiya
    • MURATA, ToshikiSHINTANI, TakuyaUMEDA, MasaomiLINO, TakashiMORIWAKI, Toshiya
    • C07D231/14
    • C07D207/325C07D211/14C07D213/64C07D213/82C07D231/12C07D231/14C07D239/34C07D261/18C07D333/38
    • The present invention relates to aryl or heteroaryl amido alkane derivatives of formula (I) wherein R 6 represents carboxy or tetrazolyl, which are useful as an active ingredient of pharmaceutical preparations. The aryl or heteroaryl amido alkanes of the present invention have PGI2 antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with PGI2 activity.Such diseases include urological diseases or disorder as follows: bladder outlet obstruction, overactive bladder, urinary incontinence, detrusor hyper-reflexia, detrusor instability, reduced bladder capacity, frequency of micturition, urge incontinence, stress incontinence, bladder hyperreactivity, benighn prostatic hypertrophy (BPH), prostatitis, urinary frequency, nocturia, urinary urgency, pelvic hypersensitivity, urethritis, pelvic pain syndrome, prostatodynia, cystitis, or idiophatic bladder hypersensitivity.The compounds of the present invention are also useful for treatment of pain including, but not limited to inflammatory pain, neuropathic pain, acute pain, chronic pain, dental pain, premenstrual pain, visceral pain, headaches, and the like; hypotension;hemophilia and hemorrhage; and inflammation, since the diseases also relate to PGI2.
    • 本发明涉及式(I)的芳基或杂芳基酰氨基烷烃衍生物,其中R 6表示羧基或四唑基,其可用作药物制剂的活性成分。 本发明的芳基或杂芳基酰氨基烷烃具有PGI 2拮抗活性,可用于预防和治疗与PGI2活性相关的疾病。这些疾病包括泌尿系统疾病或病症如下:膀胱出口阻塞,膀胱过度活动症,尿失禁 ,逼尿肌超反射,逼尿肌不稳定,膀胱容量减少,排尿频率,急迫性尿失禁,压力性尿失禁,膀胱过敏反应,前列腺肥大(BPH),前列腺炎,尿频,夜尿症,尿急,盆腔超敏反应,尿道炎,盆腔疼痛 综合症,前列腺痛,膀胱炎或自发性膀胱过敏反应。本发明化合物还可用于治疗疼痛,包括但不限于炎性疼痛,神经性疼痛,急性疼痛,慢性疼痛,牙痛,经前痛,内脏痛 ,头痛等; 低血压;血友病和出血; 和炎症,因为这些疾病也与PGI2有关。
    • 3. 发明申请
    • PHENYL OR HETEROARYL AMINO ALKANE DERIVATIVES AS IP RECEPTOR ANTAGONIST
    • 作为IP受体拮抗剂的苯基或异辛烯氨基酸衍生物
    • WO2004043926A1
    • 2004-05-27
    • PCT/EP2003/011976
    • 2003-10-29
    • BAYER HEALTHCARE AGMURATA, ToshikiUMEDA, MasaomiYOSHIKAWA, SatoruURBAHNS, KlausGUPTA, JangSAKURAI, Osamu
    • MURATA, ToshikiUMEDA, MasaomiYOSHIKAWA, SatoruURBAHNS, KlausGUPTA, JangSAKURAI, Osamu
    • C07D213/64
    • C07D213/64C07C229/36C07D213/74C07D231/38C07D239/42C07D241/20C07D261/14C07D277/42C07D401/04C07D401/10C07D401/12C07D403/10C07D403/12C07D405/10
    • The present invention relates to a phenyl or heteroaryl amino alkane derivatives which are useful as an active ingredient of pharmaceutical preparations. The phenyl or heteroaryl amino alkanes of the present invention have IP receptor antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with IP receptor antagonistic activity. Such diseases include urological diseases or disorder as follows: bladder outlet obstruction, overactive bladder, urinary incontinence, detrusor hyper-reflexia, detrusor instability, reduced bladder capacity, frequency of micturition, urge incontinence, stress incontinence, bladder hyperreactivity, benighn prostatic hypertrophy (BPH), prostatitis, urinary frequency, nocturia, urinary urgency, pelvic hypersensitivity, urethritis, pelvic pain syndrome, prostatodynia, cystitis, or idiophatic bladder hypersensitivity. The compounds of the present invention are also useful for treatment of pain including, but not limited to inflammatory pain, neuropathic pain, acute pain, chronic pain, dental pain, premenstrual pain, visceral pain, headaches, and the like; hypotension; hemophilia and hemorrhage; and inflammation, since the diseases also is alleviated by treatment with an IP receptor antagonist.
    • 本发明涉及可用作药物制剂活性成分的苯基或杂芳基氨基烷烃衍生物。 本发明的苯基或杂芳基氨基烷烃具有IP受体拮抗活性,可用于预防和治疗与IP受体拮抗活性相关的疾病。 这些疾病包括泌尿系统疾病或紊乱,如下:膀胱出口阻塞,膀胱过度活动,尿失禁,逼尿肌反射反射,逼尿肌不稳定,膀胱容量减少,排尿频率,急迫性尿失禁,压力性尿失禁,膀胱反应过度,前列腺肥大 ),前列腺炎,尿频,夜尿症,尿急,盆腔超敏反应,尿道炎,盆腔疼痛综合征,前列腺痛,膀胱炎或自发性膀胱过敏。 本发明的化合物还可用于治疗疼痛,包括但不限于炎性疼痛,神经性疼痛,急性疼痛,慢性疼痛,牙痛,经前痛,内脏痛,头痛等; 低血压; 血友病和出血; 和炎症,因为这些疾病也通过用IP受体拮抗剂治疗而缓解。
    • 5. 发明申请
    • CARBOXAMIDES DERIVATIVES
    • 碳氧化物衍生物
    • WO2003106403A1
    • 2003-12-24
    • PCT/EP2003/006168
    • 2003-06-12
    • BAYER HEALTHCARE AGSHIMAZAKI, MakotoSAKURAI, OsamuHIRAI, KanakoURBAHNS, KlausYAMAMOTO, NoriyukiYOSHIKAWA, SatoruUMEDA, MasaomiTAJIMI, Masaomi
    • SHIMAZAKI, MakotoSAKURAI, OsamuHIRAI, KanakoURBAHNS, KlausYAMAMOTO, NoriyukiYOSHIKAWA, SatoruUMEDA, MasaomiTAJIMI, Masaomi
    • C07C235/34
    • C07C235/34
    • The present invention relates to carboxamides which are useful as an active ingredient of pharmaceutical preparations. The carboxamides of the present invention have IP receptor antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with IP receptor antagonistic activity.Such diseases include urological diseases or disorder as follows: bladder outlet obstruction, overactive bladder, urinary incontinence, detrusor hyper-reflexia, detrusor instability, reduced bladder capacity, frequency of micturition, urge incontinence, stress incontinence, bladder hyperreactivity, benighn prostatic hypertrophy (BPH), prostatitis, urinary frequency, nocturia, urinary urgency, pelvic hypersensitivity, urethritis, pelvic pain syndrome, prostatodynia, cystitis, or idiophatic bladder hypersensitivity.The compounds of the present invention are also useful for treatment of pain including, but not limited to inflammatory pain, neuropathic pain, acute pain, chronic pain, dental pain, premenstrual pain, visceral pain, headaches, and the like; hypotension;hemophilia and hemorrhage; and inflammation, since the diseases are alleviated by treatment with an IP receptor antagonist.
    • 本发明涉及可用作药物制剂活性成分的羧酰胺。 本发明的甲酰胺具有IP受体拮抗活性,可用于预防和治疗与IP受体拮抗作用相关的疾病。这些疾病包括泌尿系统疾病或病症如下:膀胱出口阻塞,膀胱过度活动症,尿失禁, 逼尿肌反射反射,逼尿肌不稳定,膀胱容量减少,排尿频率,急迫性尿失禁,压力性尿失禁,膀胱反应过度,前列腺肥大(BPH),前列腺炎,尿频,夜尿症,尿急,盆腔超敏反应,尿道炎,盆腔疼痛综合征 ,前列腺痛,膀胱炎或自发性膀胱过敏症。本发明的化合物还可用于治疗疼痛,包括但不限于炎症性疼痛,神经性疼痛,急性疼痛,慢性疼痛,牙痛,经前痛,内脏痛, 头痛等; 低血压;血友病和出血; 和炎症,因为通过用IP受体拮抗剂治疗来减轻疾病。